Keith Katkin – Biografia

Keith foi Director para a Syndax Pharmaceuticals, e Director da Rigel Pharmaceuticals. Keith Katkin juntou-se à Syndax Pharmaceuticals em 2022.

Keith Katkin atualmente é

• Chairman of the Board at Ambros Therapeutics - View - Ambros Therapeutics org chart

• Chairman of the Board of Directors at Eledon Pharmaceuticals - View - Eledon Pharmaceuticals org chart

• Director at Emergent BioSolutions - View - Emergent BioSolutions org chart

• Director at Syndax Pharmaceuticals - View - Syndax Pharmaceuticals org chart

Criar um alerta
para seguir a carreira de Keith Katkin.

Keith Katkin é um Bachelor of Science in Business pela Indiana University Bloomington e um Master of Business Administration pela University of California, Los Angeles - Anderson School of Management .

Eles também estudaram em Indiana University Bloomington:

• Kristin Hendrix - Meta Platforms

• Eric Dozier - Eli Lilly

• Aamir Malik - Pfizer

Encontre 0a Indiana University Bloomington

Eles também estudaram em University of California, Los Angeles - Anderson School of Management:

• Mike Hopkins - Amazon
• Elizabeth Jackson-Rietz - Apple
• Matt Poirier - Morgan Stanley

Encontre 0a University of California, Los Angeles - Anderson School of Management

Aqui estão algumas sugestões para fazer contato com sucesso.